Loading
NASDAQHealthcareBiotechnology
Latest quote
$8.01
−$0.09 · -1.11%
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Latest quote
$8.01
−$0.09 · -1.11%
After-hours
$7.9554
−$0.0546 · -0.68%
Oct 8, 7:58 PM ET
Regular session · ET · Market data may be delayed.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Day range
Current $8.01
52-week range
Current $8.01
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
30
Expensive
Sentiment
69
Bullish
Risk
59
Elevated Risk
Momentum
36
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Day range
Current $8.01
52-week range
Current $8.01
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI16.4M0.00%2.3T USD0.03%$379.56-0.39%
State Street SPDR S&P Biotech ETFXBI14.82M0.15%10.11B USD0.35%$149.29-0.63%
iShares Russell 2000 ETFIWM11.57M0.01%77.7B USD0.19%$277.57-0.05%
Vanguard Extended Market ETFVXF5.91M0.01%95.4B USD0.05%$233.13-0.15%
iShares Russell 2000 Growth ETFIWO4.05M0.03%14.04B USD0.24%$353.47-0.53%
Vanguard Russell 2000 ETFVTWO3.06M0.02%18B USD0.06%$112.1-0.10%
Vanguard U.S. Momentum Factor ETFVFMO2.05M0.10%1.9B USD0.13%$227.78-0.44%
Vanguard Health Care ETFVHT1.4M0.01%22B USD0.09%$313.85-0.46%Vanguard Morningstar Total Stock Market ETFVTIState Street SPDR S&P Biotech ETFXBIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOVanguard U.S. Momentum Factor ETFVFMOVanguard Health Care ETFVHTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.